This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +22.98% per year. These returns cover a period from January 1, 1988 through April 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cannabis ETF (YOLO) Hits New 52-Week High
by Sanghamitra Saha
This cannabis ETF hits a new 52-week high. Are more gains in store for this ETF?
Why Cannabis Stocks & ETFs Are Soaring
by Neena Mishra
Marijuana stocks are rising on hopes of favorable regulatory environment
Cannabis ETFs Hot Ahead of Elections: Here's Why?
by Sweta Killa
With the election just a day away, five states are seeking to legalize marijuana through ballot measures.
Cannabis ETFs Surge on Kamala Harris' Decriminalizing Marijuana Pledge
by Sweta Jaiswal, FRM
Democratic vice-presidential nominee Kamala Harris buoys investors' optimism on the marijuana industry by commenting favorably on the space during a debate with her Republican counterpart Mike Pence.
Top ETF Stories of Coronavirus-Induced Q2
by Sanghamitra Saha
These ETF events ruled the broader market in the second quarter.
Top ETF Stories of May
by Sanghamitra Saha
The ETF headlines in May were ruled by the reopening of economies, hopes for a COVID-19 vaccine and global economic stimulus.
4 ETF Areas Up At Least 20% in May
by Sanghamitra Saha
These ETF areas skyrocketed in May and easily beat the broader market.
How Cannabis ETFs Beat S&P 500 Past Month
by Sanghamitra Saha
Cannabis stocks and ETFs jumped last week. Here's why.
Are Marijuana Stocks, ETFs Poised for Upbeat Earnings?
by Sanghamitra Saha
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Are Marijuana Stocks & ETFs Coronavirus-Proof?
by Sanghamitra Saha
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Cannabis ETFs Are Soaring in 2020: Will the Trend Continue?
by Sweta Killa
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
What's Ahead for Marijuana ETFs After a Dismal Show in 2019?
by Sanghamitra Saha
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
Best & Worst ETF Areas of Last Week
by Sanghamitra Saha
Inside the ETF gainers and losers of last week.
Cannabis ETFs in Focus on Thanksgiving Weekend
by Sweta Killa
Cannabis spending rises over the Thanksgiving holiday period, especially Green Wednesday as well as on Black Friday.
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Top ETF Stories of October
by Sanghamitra Saha
Announcement of phase-one trade deal, Fed rate cut, moderate earnings, marijuana crash and Brexit extension regulated the ETF world in October.
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
by Sanghamitra Saha
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
Top and Flop ETFs of October
by Sanghamitra Saha
Signs of some progress in the U.S.-China trade relation, Brexit doldrums, oil price rally and mixed earnings pulled the stings of the market movement and made these ETFs winners and losers.
One More Marijuana ETF on the Block
by Sanghamitra Saha
As Global X launches a fresh pot ETF, let's explore the product in detail.
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF
by Neena Mishra
CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.
ETFs in Focus as Consolidation Drives Marijuana Industry
by Sanghamitra Saha
Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.
Marijuana & Blockchain ETFs: Should You Buy?
by Neena Mishra
Cannabis and blockchain are high-risk, high-reward areas of the market. Should investors consider these ETFs?